AJMC September 15, 2021
The fallout from COVID-19 has spotlighted the limitations of US mental health care, prompting the question if alternative treatments—like psychedelics—could help address current and impending crises.
As rates of mental illnesses brought on and exacerbated by the COVID-19 pandemic continue to climb, experts are calling for substantial changes to improve mental health care in the United States.
Economic challenges, social isolation, and protracted grief have all contributed to the stark numbers: about 1 in 4 American adults have reported symptoms of anxiety or depressive disorder throughout the pandemic, while health care workers have faced months-long exposure to trauma induced by surges of illness and death.
But largely absent from calls to action is the fact that some pharmacological treatments for mood disorders,...